Article Information
History
- March 17, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Eleanor C. Semmes1,2,
- Itzayana G. Miller2,7,
- Nicole Rodgers2,3,
- Caroline T. Phan2,
- Jillian H. Hurst4,
- Kyle M. Walsh4,5,
- Richard J. Stanton6,
- Justin Pollara2,3 and
- Sallie R. Permar2,7,*
- 1Medical Scientist Training Program, Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA
- 2Duke Human Vaccine Institute, Duke University, Durham, NC, USA
- 3Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA
- 4Department of Pediatrics, Duke University, Durham, NC, USA
- 5Department of Neurosurgery, Duke University, Durham, NC, USA
- 6Division of Infection and Immunology, School of Medicine, Cardiff University, Cardiff, UK
- 7Department of Pediatrics, Weill Cornell Medicine, New York City, NY, USA
- ↵*Corresponding author: Sallie R. Permar, MD, PhD, Email: sallie.permar{at}med.cornell.edu | Phone: (212) 746-4111, Mailing address: 525 East 68th Street, M-622, New York, NY, 10065
Posted March 17, 2023.
ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection
